Abstract
Purpose
Research in the field of vocational rehabilitation, specifically for prostate cancer, remains rare despite increasing recognition of the role of vocational interventions in other cancer groups. The aim of this review was to compile and evaluate current trends, facilitators and barriers associated with returning to work after a prostate cancer diagnosis.
Method
The literature search was conducted in March 2018 using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Forty-seven original research papers published in English in peer-reviewed journals were identified. The included studies comprised a total of 20,083 prostate cancer patients with a mean age of 61 years.
Results
The studies implied a good overall return to work prognosis in prostate cancer patients; however, these findings are not generalisable to those with physically demanding or low paid jobs, comorbid conditions or poor physical functioning.
Conclusion
The limited research investigating the long-term implications of prostate cancer indicates that there may be problems related to job retention and early unwanted retirement. Facilitators and barriers to employment after prostate cancer are identified and implications for vocational interventions and further research are discussed.
Implications for Cancer Survivors
This review helps to shed light on the barriers and facilitators to employment among prostate cancer survivors, as well as the need for further research and development in vocational rehabilitation interventions for this population.
Similar content being viewed by others
References
Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet. 2012;380(9846):1011–29.
van der Noordt M, Ijzelenberg H, Droomers M, Proper KI. Health effects of employment: a systematic review of prospective studies. Occup Environ Med. 2014;71(10):730–6.
Zagozdzon P, Parszuto J, Wrotkowska M, Dydjow-Bendek D. Effect of unemployment on cardiovascular risk factors and mental health. Occup Med. 2014;64(6):436–41.
Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care. 2007;16(1):17–25.
Mehnert A, de Boer A, Feuerstein M. Employment challenges for cancer survivors: employment challenges. Cancer. 2013;119:2151–9.
Spelten ER, Sprangers M, Verbeek J. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-oncology. 2002;11(2):124–31.
Verbeek J, Spelten E. Work. In: Feuerstein M, editor. Handbook of cancer survivorship. Berkeley: Springer; 2007. p. 381–96.
de Boer A, Taskila T, Ojajärvi A, van Dijk F, Verbeek J. Cancer survivors and unemployment - a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.
Hewitt M, Rowland J, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91.
Carlsen K, Oksbjerg Dalton S, Frederiksen K, Johansen C, Diderichsen F, Johansen C. Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health. 2008;36(2):117–25.
Hansen JA, Feuerstein M, Calvio L, Olsen C. Breast cancer survivors at work. J Occup Environ Med. 2008;50(7):777–84.
Pryce J, Munir F, Haslam C. Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil. 2007;17(1):83–92.
Escorpizo R, Reneman MF, Ekholm J, Fritz J, Krupa T, Marnetoft S-U, et al. A conceptual definition of vocational rehabilitation based on the ICF: building a shared global model. J Occup Rehabil. 2011;21(2):126–33.
Waddell G, Burton AK, Kendall NAS. Vocational rehabilitation: what works, for whom, and when? Report for the Vocational Rehabilitation Task Group, UK. 2008. London: TSO. Retrieved from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/209474/hwwb-vocational-rehabilitation.pdf. Accessed 5 Nov 2018.
World Health Organization. Latest global cancer data: cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Press Release 263. International Agency for Research on Cancer. Geneva, Switzerland, 12 September 2018. Retrieved from: https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf.
Commonwealth of Australia. Cancer Australia. Prostate Cancer Statistics. 2018. Sourced from the Australian Institute of Health and Welfare. Retrieved from: https://prostate-cancer.canceraustralia.gov.au/statistics. Accessed 5 Nov 2018.
Al-Booz H, Ash D, Bottomley DM, Carey BM. Short-term morbidity and acceptability of 125-iodine implantation for localized carcinoma of the prostate. BJU Int. 1999;83(1):53–6.
Burgio KL, Goode PS, Urban DA, Umlauf MG, Locher JL, Bueschen A, et al. Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial. J Urol. 2006;175(1):196–201.
Berger AK, Chopra S, Desai MM, Aron M, Gill IS. Outpatient robotic radical prostatectomy: matched-pair comparison with inpatient surgery. J Endourol. 2016;30(1):S52–S6.
Dahl S, Steinsvik EAS, Dahl AA, Loge JH, Cvancarova M, Fosså SD. Return to work and sick leave after radical prostatectomy: a prospective clinical study. Acta Oncol. 2014;53(6):744–51.
Bradley CJ, Oberst K, Schenk M. Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis. Psycho-Oncology. 2006;15(8):739–47.
Sveistrup J, Mortensen OS, Rosenschöld PM, Engelholm SA, Petersen PM. Employment and sick leave in patients with prostate cancer before, during and after radiotherapy. Scand J Public Health. 2016;50(3):164–9.
Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fossa SD. Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery. J Cancer Surviv. 2015;9(2):172–9.
Gordon LG, Walker SM, Mervin MC, Lowe A, Smith DP, Gardiner RA, et al. Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. Eur J Cancer Care. 2017;26(1):e12392.
Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958–65.
Dahl S, Cvancarova M, Dahl AA, Fosså SD. Work ability in prostate cancer survivors after radical prostatectomy. Scand J Urol. 2016;50(2):116–22.
Lindbohm ML, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv. 2012;6(1):72–81.
de Boer AGEM, Taskila TK, Tamminga SJ, Sietske J, Feuerstein M, Frings-Dresen MHW, et al. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2015;9(7):CD007569.
Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443–52.
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Pluye P, Robert E, Cargo M, Bartlett G, O’Cathain A, Griffiths F, et al. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. Retrieved from: http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteriamanual_2018-08-01_ENG.pdf. Accessed 7 Sept 2018.
Souto RQ, Khanassov V, Hong QN, Bush P, Vedel I, Pluye P. Systematic mixed studies reviews: updating results on the reliability and efficiency of the mixed methods appraisal tool. Int J Nurs Stud. 2015;52(1):500–1.
Recklitis CJ, Zhou ES, Zwemer EK, Hu JC, Kantoff PW. Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. Cancer. 2014;120(21):3393–400.
Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psycho-Oncology. 2002;11(3):188–98.
Plym A, Chiesa F, Voss M, Holmberg L, Johansson E, Stattin P, et al. Work disability after robot-assisted or open radical prostatectomy: a nationwide, population-based study. Eur Urol. 2016;70(1):64–71.
Robinson JW, Saliken JC, Donnelly BJ, Barnes P, Guyn L. Quality-of-life outcomes for men treated with cryosurgery for localized prostate carcinoma. Cancer. 1999;86(9):1793–801.
Ross L, Petersen MA, Johnsen AT, Lundstroem LH, Carlsen K, Groenvold M. Factors associated with Danish cancer patients’ return to work. A report from the population-based study ‘The Cancer Patient’s World’. Cancer Epidemiol. 2012;36(2):222–9.
Sjövall K, Attner B, Englund M, Lithman T, Noreen D, Gunnars B, et al. Sickness absence among cancer patients in the pre-diagnostic and the post-diagnostic phases of five common forms of cancer. Support Care Cancer. 2012;20(4):741–7.
Ullrich A, Rath HM, Otto U, Kerschgens C, Raida M, Hagen-Aukamp C, et al. Outcomes across the return-to-work process in PC survivors attending a rehabilitation measure-results from a prospective study. Support Care Cancer. 2017;25(10):1–9.
Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.
Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv. 2011;5(4):382–94.
Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Investig. 2007;25(1):47–54.
Gudbergsson SB, Fosså SD, Borgeraas E, Dahl AA. A comparative study of living conditions in cancer patients who have returned to work after curative treatment. Support Care Cancer. 2006;14(10):1020–9.
Torp S, Nielsen RA, Gudbergsson SB, Fosså SD, Dahl AA. Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study. J Cancer Surviv. 2012;6(3):315–23.
Angenete E, Angerås U, Börjesson M, Ekelund J, Gellerstedt M, Thorsteinsdottir T, et al. Physical activity before radical prostatectomy reduces sick leave after surgery: results from a prospective, non-randomized controlled clinical trial (LAPPRO). BMC Urol. 2016;16(1):50.
Bennett JA, Brown P, Cameron L, Whitehead LC, Porter D, McPherson KM. Changes in employment and household income during the 24 months following a cancer diagnosis. Support Care Cancer. 2009;17(8):1057–64.
Gunnarsdottir HK, Vidarsdottir H, Rafnsdottir GL, Tryggvadottir L, Olafsdottir EJ, Lindbohm M-L. Employment participation and work experience of male cancer survivors: a NOCWO study. Work. 2013;46(4):385–93.
Lindbohm ML, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, et al. Cancer as the cause of changes in work situation (a NOCWO study). Psycho-Oncology. 2011;20(8):805–12.
Watts S, Leydon G, Eyles C, Moore CM, Richardson A, Birch B, et al. A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance. BMJ Open. 2015;5(5):e006674.
Zheng Z, Yabroff KR, Guy GP Jr, Han X, Li C, Banegas MP, et al. Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the United States. J Natl Cancer Inst. 2016;108(5):djv382.
Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB. The burden of out-of-pocket and indirect costs of prostate cancer. Prostate. 2010;70(11):1255–64.
Syse A, Tretli S, Kravdal Ø. Cancer’s impact on employment and earnings—a population-based study from Norway. J Cancer Surviv. 2008;2(3):149–58.
Torvinen S, Färkkilä N, Roine RP, Sintonen H, Saarto T, Taari K. Costs in different states of prostate cancer. Acta Oncol. 2016;55(1):30–7.
Shahinian VB, Kuo Y-F, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154–64.
Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA. 2005;294(2):238–44.
Funding
This study was conducted with funding assistance from the National Health and Medical Research Centre, Centre of Research Excellence in Prostate Cancer Survivorship, Griffith University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The study has not been presented elsewhere.
Appendices
Appendix 1. MEDLINE search strategy
-
1.
(MH “Prostatic Neoplasms”) OR “Prostatic Neoplasm”
-
2.
(MH “Prostate”) OR “prostate”
-
3.
(MH “Neoplasms”) OR “neoplasms”
-
4.
S2 AND S3
-
5.
“prostat* N3 (cancer* OR carcinoma* OR malig* or tumor* OR neoplas* OR metastas* OR adreno*)\
-
6.
S1 OR S4 OR S5
-
7.
“return-to-work”
-
8.
(MH “Employment”)
-
9.
“employment”
-
10.
(MH “Unemployment”)
-
11.
“unemployment”
-
12.
(MH “Unemployment”)
-
13.
MH “Sick Leave”)
-
14.
“sick leave”
-
15.
“sickness absence”
-
16.
(MH “Absenteeism”)
-
17.
“Absenteeism”
-
18.
“disability management”
-
19.
(MH “Rehabilitation, Vocational”)
-
20.
“vocational rehabilitation”
-
21.
“work retention”
-
22.
“job retention”
-
23.
“workability”
-
24.
“work ability”
-
25.
“work capacity”
-
26.
“employability”
-
27.
employable
-
28.
“return to work”
-
29.
MH retirement
-
30.
retirement
-
31.
S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28
-
32.
(MH “Return to Work”) OR ““return to work”” OR ““return-to-work”” OR (MH “Employment”) OR ““employment”” OR (MH “Unemployment”) OR ““unemployment”” OR (MH “Sick Leave”) OR ““sick leave”” OR ““sickness absence”” OR (MH “Absenteeism”) OR ““absenteeism”” OR ““disability management”” OR (MH “Rehabilitation, Vocational”) OR ““vocational rehabilitation”” OR ““work retention”” OR ““workability”” OR ““work ability”” OR ““work capacity”” OR ““employability”” OR ““employable””
-
33.
Limiters - Abstract Available; English Language; Publication Type: Journal Article; Language: Czech, English, Slovak Search modes - Boolean/Phrase
Appendix 2. EMBASE, CINAHL, and PsycINFO: identical search strategy via Ovid
-
1.
MeSH descriptor: [Prostatic Neoplasms] explode all trees
-
2.
MeSH descriptor: [Prostate] explode all trees
-
3.
MeSH descriptor: [Neoplasms] explode all trees
-
4.
S2 AND S3
-
5.
prostat* near/3 (cancer* or carcinoma* or malig* or tumo?r* or neoplas* or metastas* or adreno*)
-
6.
S1 OR S4 OR S5
-
7.
MeSH descriptor: [Return to Work] explode all trees
-
8.
MeSH descriptor: [Employment] explode all trees
-
9.
MeSH descriptor: [Unemployment] explode all trees
-
10.
MeSH descriptor: [Sick Leave] explode all trees
-
11.
MeSH descriptor: [Absenteeism] explode all trees
-
12.
MeSH descriptor: [Rehabilitation, Vocational] explode all trees
-
13.
S7 or S8 or S9 or S10 or S11 or S12
-
14.
S6 and S13 in Trials
Appendix 3. Scopus
(TITLE-ABS-KEY (“return to work” OR “employment” OR “unemployment” OR “sick leave” OR “absenteeism” OR “vocational rehabilitation” OR “disability management” OR “retirement” OR “sick leave” OR “sickness absence” OR “work capacity” OR “work retention”) ) AND ( ( TITLE-ABS-KEY (“prostatic neoplasms”) ) OR (TITLE-ABS-KEY ( “prostate cancer” ) ) ) AND ( LIMIT-TO ( DOCTYPE, “ar” ) ) AND ( LIMIT-TO ( LANGUAGE, “English” ) OR LIMIT-TO ( LANGUAGE, “Czech” ) ) AND (LIMIT-TO ( SRCTYPE, “j” ) )
Rights and permissions
About this article
Cite this article
McLennan, V., Ludvik, D., Chambers, S. et al. Work after prostate cancer: a systematic review. J Cancer Surviv 13, 282–291 (2019). https://doi.org/10.1007/s11764-019-00750-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-019-00750-4